Drug · DIN 02369362
ACUVAIL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 4, 2024; first marketed January 10, 2012.
- Drug Identification Number (DIN)
- 02369362
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Ketorolac S01BC05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| KETOROLAC TROMETHAMINE | 0.45 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 16, 2022: NOC 29482New Drug Submission (NDS) · Administrative: Merger/Buy-out
- June 15, 2011: NOC 12432New Drug Submission (NDS)